- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07701174
Weighted Dangling Exercises vs Vastus Medialis Oblique Muscle Neuromuscular Stimulation for Knee Osteoarthritis
Effectiveness of Weighted Dangling Exercises Versus Vastus Medialis Oblique Muscle Neuromuscular Stimulation in Patients With Knee Osteoarthritis
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Ishaq Ahmed, PhD PT
- Telefonnummer: 03344066463
- E-post: ishaq.ahmed@uipt.uol.edu.pk
Studera Kontakt Backup
- Namn: Ashfaq Ahmed, PhD PT
- Telefonnummer: 03009449192
- E-post: ashfaq.ahmed@uipt.uol.edu.pk
Studieorter
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekrytering
- University of Lahore Teaching Hospital, Lahore, Pakistan
-
Kontakt:
- Asim Arif, PhD PT*
- Telefonnummer: 03216597727
- E-post: asim.arif@uipt.uol.edu.pk
-
Kontakt:
- Mahnoor Fatima, MS MSK*
- Telefonnummer: 03164247896
- E-post: 70174837@student.uol.edu.pk
-
Huvudutredare:
- Mahnoor Fatima, MS MSK
-
Huvudutredare:
- Hafiza Sana Ashraf, PhD PT*
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
Both genders and aged between 40 and 60 years. Symptoms of unilateral knee pain and crepitus persist for at least 6 months during ascending and descending motion. Radiographic KOA; grade 2 or more according to Kellgren and Lawrence scale. Patient referred by an orthopedic physician Those who have taken oral corticosteroids within the last month or who received intra-articular corticosteroid injection or analgesic injection intervention for hip or knee pain within the last 3 month
Exclusion Criteria:
- Recent surgery (within three months) history of hip or knee joint replacement, tibial osteotomy, orthoses with systemic arthritis, history of trauma such as knee fracture and other with muscular disease of neurological disorders that would affect lower extremity function is excluded.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: interventional group A
The experimental group A will receive weighted dangling exercise.
A gravity-assisted flexion-extension movements of the lower legs Ankle cuffs weight worn during the exercise while seated on a high couch with their legs hanging down
|
This group receive neuromuscular electrical stimulation (NMES) specifically targeting the vastus medialis oblique (VMO).
The NMES parameters are as follows: electrodes were placed above the superomedial border of the patella, oriented at a 55° angle to the vertical.
The stimulation frequency set at 50 Hz, with a pulse duration of 250 µs and a duty cycle of 10 seconds ON and 30 seconds OFF
|
|
Aktiv komparator: interventional group B
Experimental group B receive neuromuscular electrical stimulation (NMES) specifically targeting the vastus medialis oblique (VMO).
The NMES parameters are as follows: electrodes were placed above the superomedial border of the patella, oriented at a 55° angle to the vertical.
The stimulation frequency set at 50 Hz, with a pulse duration of 250 µs and a duty cycle of 10 seconds ON and 30 seconds OFF
|
The one group will receive weighted dangling exercise.
A gravity-assisted flexion-extension movements of the lower legs Ankle cuffs weight worn during the exercise while seated on a high couch with their legs hanging down
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Pain Intensity (Numeric Pain Rating Scale)
Tidsram: baseline,4 weeks and 8 weeks
|
Pain in this study is defined as subjective discomfort in the knee joint caused by osteoarthritis.
It was evaluated using the Numeric Pain Rating Scale (NPRS), which is a reliable and proven technique for quantifying pain intensity.
Participants score their discomfort on an 11-point scale, with 0 indicating "no pain" and 10 representing "the worst pain imaginable.
|
baseline,4 weeks and 8 weeks
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Functional disability:(WOMAC)
Tidsram: Baseline 4 weeks and 8 weeks
|
Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), which is a well-used and validated questionnaire.
The WOMAC measures three dimensions: pain (5 things), stiffness (2 items), and physical function (17 items).
Each item is assessed on a scale of 0 (no difficulty) to 4 (severe difficulty), with a total WOMAC score of 0-96.
Higher scores indicate greater functional disability.
The questionnaire examines pain while walking or ascending stairs, stiffness in the morning or later in the day, and difficulty with sitting, standing, and lifting objects.
|
Baseline 4 weeks and 8 weeks
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Mahnoor Fatima, MS MSK*, University Institute of Physical Therapy, University of Lahore
- Huvudutredare: Hafiza Sana Ashraf, PhD PT*, University Institute of Physical Therapy, University of Lahore
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- UOL/IREB/25/15/03/26 (Annan identifierare: University Of Lahore)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .